Corteva, Inc. (CTVA) intrinsic value & 10-year financials
Corteva, Inc. (CTVA) has a Graham intrinsic value of $33.82 per share. At $12.88 on Oct 17, 2026, the stock trades 62% below that value. Over the last 10 fiscal years revenue grew 2.9% a year to $17.4B, with an average return on invested capital of 2.4%.
- Graham intrinsic value
- $33.82
- Share price (Oct 17, 2026)
- $12.88
- Price vs Graham value
- 62% below
- Market cap
- $8.8B
- Revenue (FY2025)
- $17.4B
- Revenue growth (10-yr CAGR)
- 2.9%
- ROIC (10-yr avg)
- 2.4%
- Free cash flow (FY2025)
- $2.8B
CTVA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $17.4B | $1.1B | $1.60 | $2.8B | — | 5.0% |
| FY2024 | $16.9B | $907.0M | $1.30 | $1.5B | — | 3.8% |
| FY2023 | $17.2B | $735.0M | $1.03 | $1.2B | — | 3.1% |
| FY2022 | $17.5B | $1.1B | $1.58 | $267.0M | — | 5.1% |
| FY2021 | $15.7B | $1.8B | $2.37 | $2.2B | — | 7.9% |
| FY2020 | $14.2B | $681.0M | $0.91 | $1.6B | — | 3.0% |
| FY2019 | $13.8B | -$959.0M | -$1.28 | -$93.0M | — | -1.9% |
| FY2018 | $14.3B | -$5.1B | -$6.76 | -$1.0B | — | -6.5% |
| FY2017 | — | — | — | — | — | — |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Corteva revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Corteva has historically struggled to out-earn its cost of capital, averaging just 2.4% ROIC.
Corteva capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Corteva is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $33.82 per share.